Antivirals for influenza: where now for clinical practice and pandemic preparedness?
Division of Epidemiology and Public Health, University of Nottingham, Nottingham NG5 1PB, UK. Electronic address: jvt@nottingham.ac.uk.
Jonathan S
JS
Nguyen-Van-Tam
National Heart and Lung Institute, Imperial College, London, UK.
Peter J M
PJ
Openshaw
Department of Infection, Immunity and Inflammation, University of Leicester, Leicester.
Karl G
KG
Nicholson
D000998:Antiviral Agents / Q000627:therapeutic use*; D002648:Child; D006801:Humans; D007251:Influenza, Human / Q000188:drug therapy*; D009439:Neuraminidase / Q000037:antagonists & inhibitors*; D053139:Oseltamivir / Q000627:therapeutic use; D058873:Pandemics; D053243:Zanamivir / Q000627:therapeutic use
D000998:Antiviral Agents; D053139:Oseltamivir; D009439:Neuraminidase; D053243:Zanamivir